An investigator-initiated, phase II clinical trial of the peptide-based cancer vaccine targeting WT1, DSP-7888, for colorectal adenomas in familial adenomatous polyposis
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2613425
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Induction phase: intradermal administration of DSP-7888 dosing emulsion 3.5mg once every 14 days for 2 months (5 times in total)
Maintenance phase: intradermal administration of DSP-7888 dosing emulsion 3.5mg once every 28 days for 6 months (6 times in total)
Primary outcome(s): Percentage of patients with newly detected polyps of >=5 mm in diameter in the colon and/or rectum
Study Design: single arm study, open(masking not used), uncontrolled control, single assignment, treatment purpose
创建时间：
2020-12-15
